Samsung Biologics partners with LegoChem Biosciences for ADC development and manufacturing

- Samsung Biologics to develop and manufacture antibody for ADC candidate - Latest deal comes as Samsung Biologics is on track to complete construction of an ADC facility this year INCHEON, South Korea, Feb. 7, 2024

Related Keywords

South Korea ,Incheon ,Inch On Gwangyoksi ,Samsung Biologics ,Claire Kim ,Prnewswire Samsung Biologics ,Daeyoung Jeong ,Samsung Biologics America ,Legochem Biosciences ,Samsung Life Science Fund ,Team Leader ,Legochem Biosciences Inc ,Head Of Marketing Communications ,Samsung Biologics Co Ltd ,Legochem Bioscience ,Chem Biosciences ,Investigational New Drug ,John Rim ,Yong Zu Kim ,Bio Campus ,